Halal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmaceuticals refer to medicines that should not contain any parts of animals (dogs, pigs and ones particularly with pointed teeth), insects (bees), alcohol and other substances prohibited as 'haram' under the Shariah law.
In the last several years, global market of Halal Pharmaceuticals developed rapidly, with an average growth rate of 22.98%. In the next few years, Halal Pharmaceuticals industry will maintain increasing at a high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
Market Analysis and Insights: Global Halal Pharmaceuticals Market
The global Halal Pharmaceuticals market was valued at US$ 391.9 in 2020 and will reach US$ 803.1 million by the end of 2027, growing at a CAGR of 12.7% during 2022-2027.
Global Halal Pharmaceuticals Scope and Market Size
The global Halal Pharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Halal Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Tablets
Syrups
Capsules
Others
Segment by Application
Health Care Products
Drugs
The Halal Pharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Halal Pharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
CCM Pharmaceuticals
Pharmaniaga
Rosemont Pharmaceuticals
Simpor Pharma
Bosch Pharmaceuticals
NOOR VITAMINS
In the last several years, global market of Halal Pharmaceuticals developed rapidly, with an average growth rate of 22.98%. In the next few years, Halal Pharmaceuticals industry will maintain increasing at a high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
Market Analysis and Insights: Global Halal Pharmaceuticals Market
The global Halal Pharmaceuticals market was valued at US$ 391.9 in 2020 and will reach US$ 803.1 million by the end of 2027, growing at a CAGR of 12.7% during 2022-2027.
Global Halal Pharmaceuticals Scope and Market Size
The global Halal Pharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Halal Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Tablets
Syrups
Capsules
Others
Segment by Application
Health Care Products
Drugs
The Halal Pharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Halal Pharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
CCM Pharmaceuticals
Pharmaniaga
Rosemont Pharmaceuticals
Simpor Pharma
Bosch Pharmaceuticals
NOOR VITAMINS
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.